Welcome to our dedicated page for Freenome SEC filings (Ticker: PCSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Freenome's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Freenome's regulatory disclosures and financial reporting.
Freenome Holdings announced top-line results from a pivotal validation study of its updated SimpleScreen™ CRC blood test showing the study met its primary and secondary endpoints. The updated test achieved 80.4% sensitivity for colorectal cancer (CRC) and 18.2% sensitivity for advanced precancerous lesions (APLs); specificity for no findings on colonoscopy was 90%. The study included data from the PREEMPT CRC prospective registrational study of 48,995 adults and analysis cohorts of >85 CRC cases, 1,500 APLs, and 150 APLs with high-grade dysplasia (HGD). Modeling reported a projected 7.7% increase in life-years gained and 9.5% fewer CRC cases and deaths per 100,000 screened versus the first-generation test. Freenome says it plans to submit a supplemental PMA for the next-generation test and notes a $70 million milestone payment to Abbott is conditioned on FDA approval and successful technology transfer.
Perceptive Capital Solutions Corp postponed its Extraordinary General Meeting originally scheduled for July 9, 2026 and will now hold the meeting on July 15, 2026 to allow time to supplement the proxy statement/prospectus and continue proxy solicitation in connection with the proposed business combination with Freenome Holdings, Inc.
The deadline for delivery of redemption demands has been extended to 5:00 p.m. Eastern Time on July 13, 2026. Shares of record as of June 12, 2026 remain entitled to vote. The filing notes the Form S-4 registration statement was declared effective on June 17, 2026.
Perceptive Capital Solutions Corp. is postponing its extraordinary general meeting to vote on the proposed business combination with Freenome. The meeting, originally set for July 9, 2026, will now take place on July 15, 2026 at 10:00 a.m. Eastern Time in New York and via virtual webcast.
The delay is intended to give PCSC and Freenome time to supplement the proxy statement/prospectus with information on recent events and to continue soliciting proxies. PCSC has also extended the deadline for Class A shareholders to submit redemption demands to 5:00 p.m. Eastern Time on July 13, 2026, while maintaining June 12, 2026 as the record date for voting.
Perceptive Capital Solutions Corp filings show Point72-related entities report beneficial ownership of 465,000 shares of Class A Ordinary Shares. The statement, filed as a Schedule 13G, records this position as 5.7% of the class as of July 7, 2026.
The filing is made jointly by Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen and notes that Point72 Associates holds the shares and that Point72 Asset Management maintains investment and voting power pursuant to an investment management agreement.
Perceptive Capital Solutions Corp (PCSC) and Freenome Holdings, Inc. announced the Registration Statement on Form S-4 was declared effective by the SEC on June 17, 2026. The filing includes a combined proxy statement/prospectus for the proposed business combination that will be mailed to PCSC shareholders of record as of June 12, 2026.
The business combination is governed by a definitive Business Combination Agreement dated December 5, 2025. Upon closing, PCSC will be renamed Freenome, Inc.. The proxy/prospectus contains information for shareholders to consider when voting on the transaction.
Perceptive Capital Solutions Corp reported that its joint Registration Statement on Form S-4 with Freenome Holdings, Inc., related to their proposed business combination, was declared effective by the SEC on June 17, 2026. This clears a key regulatory step for taking Freenome public via PCSC’s SPAC structure.
The companies have scheduled an extraordinary general meeting of PCSC shareholders for July 9, 2026 to vote on the transaction, using a definitive proxy statement/prospectus mailed to shareholders of record as of June 12, 2026. If closing conditions are met, PCSC will be renamed Freenome, Inc. after the business combination.
Perceptive Capital Solutions Corp proposes to consummate a business combination with Freenome and register up to 82,313,492 shares of New Freenome Common Stock. The transaction contemplates domestication to Delaware, two-step mergers, and a PIPE Financing of 24,000,000 shares for $240.0 million at $10.00 per share.
The proxy/prospectus describes redemption mechanics (estimated trust balance $85,168,067 as of June 10, 2026 and an illustrative per-share redemption price of ~$10.82), ownership pro forma scenarios under an estimated redemption case, director and sponsor lock-ups, investor rights and customary closing conditions including Nasdaq listing approval.
Perceptive Capital Solutions Corp. (PCSC) filed Amendment No. 3 to a Form S-4/A that refiles its proxy statement/prospectus in full and adds an omitted iXBRL exhibit. The prospectus covers up to 82,313,492 shares of New Freenome Common Stock to be issued in connection with a proposed business combination with Freenome Holdings, Inc.
The transaction contemplates a domestication of PCSC to Delaware, two-step mergers, and a $240.0 million PIPE Financing (24,000,000 PIPE Shares at $10.00 per share). As of June 10, 2026, approximately $85,168,067 remained in the trust account and PCSC extended its deadline to complete an initial business combination to June 13, 2027.
Perceptive Capital Solutions Corp (PCSC) filed an amended Form S-4 proxy statement/prospectus for the proposed business combination with Freenome, including a prospectus covering 82,313,492 shares of New Freenome Common Stock. The transaction contemplates domestication to Delaware, a two-step merger structure and a PIPE Financing of $240.0 million for 24,000,000 PIPE Shares at $10.00 per share, subject to Nasdaq listing confirmation and various closing conditions. As of June 10, 2026, the trust account held $85,168,067, 754,008 Class A shares were redeemed for approximately $8.2 million at about $10.82 per share, and 7,870,992 Class A shares remained outstanding. The extraordinary general meeting to vote on the combination is scheduled for July 9, 2026.